Zurueck zur Suche

Reporte zur Charge GF3N2

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 3 MO 2 OH 2 VT 1 PA 1 KS 1 VA 1

VAERS 2482880

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge GF3N2

moderat
Staat
MO
Alter
44,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Hypoaesthesia Immediate post-injection reaction Joint swelling Pain Paraesthesia Pyrexia Rash erythematous Tremor

Symptomtext

immediate palpitations and shakes x 30 minutes, 2 days later severe body aches and fever, sunburn like rash x 24 hrs, , continued pain and swelling of the joints with numbness and tingling of the extremities

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2478460

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

moderat
Staat
MI
Alter
47,0
Geschlecht
F
Eingang
14.10.2022
Impfdatum
07.10.2022
Beginn
12.10.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Migraine Musculoskeletal stiffness Nausea Neck pain

Symptomtext

migraine headache started on 10/12, continued through 10/13. I have a history of migraines, this event was not unusual and I do not believe it related to the vaccinates received on 10/07/2022. Symptoms included neck and head pain, neck stiffness, mild nausea intermittently. I saw provider at Clinic for pain relief related to migraine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
no tests for this. Medications received for the migraine at Clinic were as follows: Toradol 30 mg IM injection and Solumedrol 125 mg IM injection. Oral Zofran 8 mg tablets prescribed to take as needed. None have been taken as nausea, I have not taken any Zofran as nausea has gone away. Migraine pain is also resolved as of approximately 7 pm October 13, 2022.
Aktuelle Erkrankungen
none
Vorgeschichte
asthma, migraines, depression
Andere Medikamente
omeprazole 20 mg, women's multivitamin, Tylenol extra-strength as needed, Celexa 10 mg, probiotic, osteo-biflex
Allergien
codeine
Vorherige Impfungen
-

VAERS 2469771

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

moderat
Staat
MO
Alter
42,0
Geschlecht
F
Eingang
05.10.2022
Impfdatum
28.09.2022
Beginn
04.10.2022
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Mobility decreased Pain in extremity

Symptomtext

Patient reports pain and limited mobility due to pain in Left arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Humira, Plaquenil, Celebrix
Allergien
Tamiflu
Vorherige Impfungen
-

VAERS 2500630

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

mild
Staat
VT
Alter
38,0
Geschlecht
F
Eingang
07.11.2022
Impfdatum
02.11.2022
Beginn
02.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Rash erythematous

Symptomtext

Patient states, "I received my flu shot on Wednesday that night I noticed bumps on my left forearm. Thursday they were red and today have a slight burning sensation. It is also on the left side of my face".

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Acute frontal sinusitis Asthma Heart palpitations Raynaud disease
Andere Medikamente
acetaminophen (Tylenol) 325 mg Tablet albuterol 90 mcg/actuation HFA Aerosol Inhaler
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2498598

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

mild
Staat
PA
Alter
4,0
Geschlecht
F
Eingang
04.11.2022
Impfdatum
01.11.2022
Beginn
02.11.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Injection site vesicles

Symptomtext

Swelling, redness of the admin the morning by 11/3/22 in the morning large blisters formed at the site Mupirocin and reflex initially given in the morning then discountinued and started on prednisone that same night

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Bronchiolitis
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2478627

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

mild
Staat
KS
Alter
49,0
Geschlecht
F
Eingang
14.10.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Injection site erythema Injection site pruritus Injection site swelling Pruritus Urticaria

Symptomtext

Reported itching, redness, swelling at injection site approx 15 minutes after receiving. Given Claritin. After another 15 minutes, reported full-body itching and hives. Sent to ED for further treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2466639

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

mild
Staat
MI
Alter
0,5
Geschlecht
M
Eingang
01.10.2022
Impfdatum
01.10.2022
Beginn
01.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Vomiting

Symptomtext

Patient was fine after receiving the vaccine until he was put into his car seat approximately 10 minutes after getting the vaccine. At that time, he threw up. According to his parents, it was the entire content of his stomach. They returned to the waiting area and requested to be seen by a nurse. I met them and assessed patient. His color was normal, breathing was normal, and was smiling. They waited an additional 20 minutes; I checked on them again and he was fine; normal color, breathing, and smiling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2563961

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge GF3N2

gering
Staat
VA
Alter
44,0
Geschlecht
F
Eingang
20.01.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Exposure via skin contact Incorrect dose administered

Symptomtext

Patient didn't receive full dose; Leakage from needle to arm; Leakage from needle to arm; This case was reported by a nurse via call center representative and described the occurrence of incomplete dose administered in a 44-year-old female patient who received Flu Seasonal QIV (FluLaval Quadrivalent 2022-2023 season) (batch number GF3N2, expiry date 30th June 2023) for prophylaxis. Co-suspect products included flu seasonal qiv pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 4th January 2023, the patient received FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device. On 4th January 2023, unknown after receiving FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine. On an unknown date, the outcome of the incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 09 JAN 2023 Reporters comment: Registered Nurse called to inquire should patient repeat the dose. The nurse reported that the patient administered a Flulaval dose. The nurse administered the dose and withdrew the needle from the patient's arm, vaccine came out. The patient did not receive the full dose of vaccine. RN confirmed not the leakage from prefilled syringe portion but from needle to arm. The reporter did not consent to follow up. Additional supportive information: As patient didn't receive the full dose of vaccine, which led to incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2514194

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

gering
Staat
OH
Alter
66,0
Geschlecht
F
Eingang
22.11.2022
Impfdatum
22.11.2022
Beginn
22.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

INADVERTANTLY GAVE REGULAR DOSE FLU INSTEAD OF HIGH DOSE- (WAS AVAILABLE) CLIENT NOTIFIED BY RN

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NO
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
NO
Vorherige Impfungen
-

VAERS 2514176

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

gering
Staat
OH
Alter
67,0
Geschlecht
M
Eingang
22.11.2022
Impfdatum
22.11.2022
Beginn
01.11.2022
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

INADVERTANTLY GAVE REGULAR DOSE INSTEAD OF HIGH DOSE- (WAS AVAILABLE) CLIENT NOTIFIED BY NURSE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
NONE
Andere Medikamente
UNKNOWN
Allergien
NO
Vorherige Impfungen
-

VAERS 2475228

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge GF3N2

gering
Staat
MI
Alter
33,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Swollen tongue Throat irritation

Symptomtext

Patient with throat itchiness and tounge swelling. Took Benadryl but that did not seem to help with symptoms. Went to ED for further observation . She was given steriods and famotidine for treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Swollen tongue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-